Publication | Open Access
Altered pulmonary blood volume distribution as a biomarker for predicting outcomes in COVID-19 disease
32
Citations
20
References
2021
Year
The data suggest BV5% as a novel biomarker for predicting adverse outcomes in patients with COVID-19 seeking acute medical care.
| Year | Citations | |
|---|---|---|
Page 1
Page 1